Morgan Stanley advice for Vertex Pharma
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| December 20, 2018 | Morgan Stanley | Vertex Pharma | Buy | 210.00 USD | -3.64 % |
Advice details
New York - Op 20 dec herhalen de analisten van Morgan Stanley hun koopadvies voor Vertex Pharma (ISIN: US92532F1003 / Mnemo: VRTX). Het 12-maands koersdoel wordt opwaarts bijgesteld van 207.0 USD naar 210.0 USD.
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2024 ValueSpectrum. All Rights Reserved
Developed and maintained by 